New York City, NY -- (SBWIRE) -- 12/13/2013 -- StockMarketIntel.com issues a special report on the following stocks: Baxano Surgical Inc (NASDAQ:BAXS), Sigma Labs Inc (OTCMKTS:SGLB), MannKind Corporation (NASDAQ:MNKD), Northwest Biotherapeutics, Inc (NASDAQ:NWBO)
Baxano Surgical Inc (NASDAQ:BAXS) gained 13.54%, trading on 2.92 million shares, to end the trade at $1.09. The stock changed hands in a range of $1.05 to $1.43, bringing its market capitalization to about $49.27 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.92 and was moved to the maximum level of $2.80. Baxano Surgical, Inc., a medical device company, designs, develops, and markets minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. It markets the AxiaLIF family of products for single and two level lower lumbar fusion; the VEO lateral access and interbody fusion system; the iO-Flex system, a proprietary set of flexible instruments used by surgeons during spinal decompression procedures; and the iO-Tome instrument, which removes bone, primarily the facet joints.
For How Long BAXS will fight for Profitability? Read This Trend Analysis report
Sigma Labs Inc (OTCMKTS:SGLB) added 18.23%, to complete the trading session at $0.214, with a total volume of 4.59 million shares. The stock, on average, trades on a volume of 7.41 million shares. It floated in a range of $0.17 to $0.21 during the last trading session, with a beta value of 7.35. Its market capitalization now moved to about $118.77 million. In the past 52 weeks, the share price has not declined below $0.01 and above $0.28. Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions. It also focuses on commercializing technologies and products in various industry sectors, such as in process quality assurance for manufacturing; aerospace and defense manufacturing; additive manufacturing; active protection systems for defending light armored vehicles; advanced materials for munitions; advanced materials for sporting goods; advanced manufacturing technologies; and dental implant and biomedical prosthetics technologies.
For How Long SGLB Gloss will Attract Investors? Find out via this report
MannKind Corporation (NASDAQ:MNKD) recorded a gain of 3.12% and was in a range of $4.58-$5.01 before closing at $4.96. The stock completed the day with a total volume of 5.64 million shares, versus an average volume of 4.59 million shares. The share price hit its 52-week low of $2.09 and $8.70 was the best price. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia.
Will MNKD Continue To Move Higher? Find Out Here
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) declined -12.15% yesterday, bringing its market capitalization around $150.61 million. The share price, after opening at $3.74, made a high of $3.74 and hovered above $3.30 to end the day at $3.47. The total number of shares that changed hands during the session was 2.60 million shares, as compared to average trading volume of 1.55 million shares. Northwest Biotherapeutics, Inc., a development stage biotechnology company, engages in discovering, developing, and commercializing immunotherapy products to treat cancers in the United States. Its DCVax uses activated dendritic cells to mobilize a patient?s own immune system to attack their cancer.
Has NWBO Found The Bottom and Ready To Move Up? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)